CSIMarket
 
West Pharmaceutical Services Inc   (WST)
Other Ticker:  
 
 
Price: $331.6600 $3.07 0.934%
Day's High: $332.1 Week Perf: -3.24 %
Day's Low: $ 326.00 30 Day Perf: -9.92 %
Volume (M): 386 52 Wk High: $ 415.73
Volume (M$): $ 127,988 52 Wk Avg: $368.44
Open: $327.45 52 Wk Low: $310.42



 Market Capitalization (Millions $) 24,642
 Shares Outstanding (Millions) 74
 Employees 10,065
 Revenues (TTM) (Millions $) 2,928
 Net Income (TTM) (Millions $) 569
 Cash Flow (TTM) (Millions $) -285
 Capital Exp. (TTM) (Millions $) 371

West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. and its majority-owned subsidiaries is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Our products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.


   Company Address: 530 Herman O. West Drive Exton 19341 PA
   Company Phone Number: 594-2900   Stock Exchange / Ticker: NYSE WST
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



West Pharmaceutical Services Inc

West Pharmaceutical Services Inc Faces Challenges with Disappointing First-Quarter Results

Investors in West Pharmaceutical Services Inc (NYSE: WST) may be feeling concerned following the disappointing first-quarter results announced by the company. The earnings per share deteriorated by -16.22% to $1.55 from $1.85, and revenue sunk by -2.986% to $695.20 million in the first quarter of the 2024 earnings season, year on year.
Comparing these results to the rest of the Medical Equipment & Supplies sector, where other companies posted revenue gains in the same period, it is clear that West Pharmaceutical Services Inc is facing some challenges. Profits fell from $1.84 per share and revenue decreased by -4.962% from $731.50 million in the preceding financial reporting period. Net income also saw a decline by -17.64% to $115.300 million in the first quarter of 2024.

West Pharmaceutical Services Inc

West Pharmaceutical Services Inc Achieves Impressive 34.8% Increase in EPS in Q4 2023 Fiscal Report

In the final fiscal quarter of 2023, West Pharmaceutical Services Inc exhibited strong growth in its earnings per share, outpacing the increase in revenue. The company reported a 34.8% surge in profit per share, reaching $1.84 per share, while revenue saw a moderate increase of 3.217% to $731.50 million compared to the same quarter in the previous year. However, when compared to its competitors in the Medical Equipment & Supplies sector, West Pharmaceutical Services Inc fell short in terms of top-line growth, as the sector as a whole saw a 5.58% increase in revenue from the previous year.
In the previous quarter, the company reported revenue of $747.30 million and earnings of $2.14 per share. The bottom line for the fourth quarter of 2023 showed significant improvement, with net earnings of $137.000 million, a 33.01% increase from the same period a year ago. Profit margins also saw improvement, with net margin rising to 18.73% and operating margin increasing to 22% in the fourth quarter of 2023. Additionally, the company experienced a build-up in inventories, with levels reaching $434.7 million, higher than both the previous quarter and the same period a year ago.

West Pharmaceutical Services Inc

West Pharmaceutical Services Inc Displays Impressive Revenue Growth, Firmly Establishing It as a Dominant Player in the Pharmaceutical Packaging Industry



West Pharmaceutical Services Inc, a leading manufacturer of pharmaceutical packaging and delivery systems, recently released its financial results for the third quarter ending September 30, 2023. This article examines the key financial indicators, their implications, and how they are likely to impact the company's future performance.
Revenue Growth:
In the third quarter of 2023, West Pharmaceutical Services Inc witnessed a significant increase in revenue, reaching $747.30 million, an 8.793% rise compared to the same period the previous year. This growth demonstrates the company's ability to capture a larger market share and generate increased sales.

West Pharmaceutical Services Inc

West Pharmaceutical Services Reports Disappointing Financial Results for June 2023: EPS Drops by 16.94%, Revenue Decreases by 2.269%

Financial News Report: West Pharmaceutical Services Inc Announces Disappointing Q2 2023 Earnings
West Pharmaceutical Services Inc, a leading Medical Equipment & Supplies company, reported disappointing financial numbers for the second quarter of 2023 earnings season. The company's earnings per share (EPS) deteriorated by -16.94% to $2.06 from $2.48, while revenue decreased by -2.269% to $753.80 million compared to the same period last year.
However, it is worth noting that from the preceding financial reporting period, earnings per share grew from $1.85 per share, and revenue increased by 5.191% from $716.60 million. Despite this growth, net earnings for the second quarter of 2023 earnings season fell by -17.72% to $155.100 million from $188.500 million in the corresponding period a year before.






 

West Pharmaceutical Services Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
West Pharmaceutical Services Inc does not provide revenue guidance.

Earnings Outlook
West Pharmaceutical Services Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com